IBD Anniversary OfferIBD Anniversary Offer


Stocks Open Slightly Higher; Nike Slips After Earnings

Nike weighed heavy on early trade Wednesday, as an analyst downgrade followed its fiscal Q1 report.(iStockphoto)

Stocks opened moderately higher Wednesday, as investors looked toward the day's heavy docket of appearances by Federal Reserve officials.

The Dow industrials and S&P 500 rose 0.2% and the Nasdaq edged up 0.1%. The smalll-cap Russell 2000 was up 0.4%.

Team Yellen Speaks, Durable Goods Unchanged

A long list of Federal Reserve speeches could have some influence on the stock market today. Minneapolis Federal Reserve Bank President Neel Kashkari joined a local question-and-answer session at 8:45 a.m. ET.  Fed Chair Janet Yellen talks before the House Financial Services Committee at 10 a.m. ET. James Bullard, St. Louis Fed Bank president, delivers opening remarks at a St. Louis community banking conference at 10:15 a.m. ET, and Charles Evans of the Chicago Fed is scheduled to speak at 1:30 p.m. ET.

Durable goods orders were flat in August, the Commerce Department reported, better than economist expectations for a 1.9% decline.  July orders rose a revised 3.6% -- less than Commerce's earlier estimate of a 4.4% increase. Minus transportation, orders slipped 0.4%, down from July's 1.5% rise but better than the 0.5% slip projected by economists.

Next up: the Energy Information Administration delivers its weekly crude oil inventories data at 10:30 a.m.

In Motion: Nike, Biogen, Tempur Sealy, Cintas

Nike (NKE) fell 2% at the open. It reported late Tuesday stronger-than-expected sales and earnings for its fiscal first quarter, but weak "futures orders" forecasts disappointed investors. Brean Capital downgraded the stock from buy to hold.

Uniform supplier Cintas (CTAS) popped 4% in early trade. The Cincinnati, Ohio-based outfit reported after Tuesday's close a broad first quarter earnings beat and revenue in line with consensus expectations. The stock ended Tuesday's session pulled back from a Sept. 6 high, and testing support t its 10-week moving average.

Among IBD 50 stocks, Biogen (BIIB) eased a fraction after signing a transfer agreement with Anavex Life Sciences (AVXL) to test its Anavex 2-73 treatment for degenerative central nervous system diseases. Anavex shares spiked 46%. Biogen ended Tuesday's session about 5% below a flat base buy point of 333.75.

Tile Shop Holdings (TTS) jumped 8% at the open. Standard & Poor's announced late Tuesday the stock would join the S&P Smallcap 600 index as of the end of trade on Friday.

Mattress maker Tempur Sealy International (TPX) cratered 22% after management lowered its third-quarter and full-year revenue guidance, and dropped the midpoint of its earnings guidance by 5%.

Oil Climbs, Europe's Markets Rally

Crude oil traded higher, up about 1% with West Texas Intermediate just above $45 a barrel. Despite recent gyrations, WTI's trading range has centered at the $45 mark since mid-August.  Gold eased slightly to $1,329 an ounce. The dollar strengthened while bonds flattened, leaving the 10-year Treasury yield unchanged at 1.56%.

Overseas, Europe's markets were sharply higher and fighting for a positive finish after three days of declines. The CAC 40 in Paris and Frankfurt's DAX were each up about 1% in afternoon trade. Tokyo's Nikkei 225 ended Wednesday's session down 1.3%. China's leading benchmarks posted a narrowly-mixed finish.